Jessica Sachs Biography and Net Worth

Insider of Cogent Biosciences

Dr. Sachs has 20 years of experience, including over 12 in industry. Prior to assuming the role of Chief Medical Officer at Cogent, she served as Vice President of Clinical Sciences at Cogent, responsible for the clinical development strategy and medical and translational oversight of the Cogent portfolio. Before joining Cogent, Dr. Sachs spent several years at Takeda/Millennium where she led multiple clinical programs in oncology and transplantation, and at Genzyme Corporation, where she was responsible for post-marketing safety surveillance and risk management activities for a variety of oncology products. Dr. Sachs has been a faculty member of the Harvard Medical School since 2007 and is an Assistant in Pediatrics in the Division of Pediatric Hematology/Oncology at the Massachusetts General Hospital. She completed her fellowship in pediatric hematology and oncology at the Dana-Farber Cancer Institute and Children’s Hospital Boston. She received her MD from Washington University in St. Louis and her BS from Duke University. Jessica loves hiking, spending time outdoors, and being with her family.

What is Jessica Sachs' net worth?: The estimated net worth of Jessica Sachs is at least $5.09 million as of December 26th, 2025. Sachs owns 133,938 shares of Cogent Biosciences stock worth more than $5,094,466 as of January 14th. This net worth approximation does not reflect any other assets that Sachs may own. Additionally, Sachs receives a salary of $773,920.00 as Insider at Cogent Biosciences. Learn More about Jessica Sachs' net worth.
How old is Jessica Sachs?: Sachs is currently 49 years old. There are 3 older executives and no younger executives at Cogent Biosciences. Learn More on Jessica Sachs' age.
What is Jessica Sachs' salary?: As the Insider of Cogent Biosciences, Inc., Sachs earns $773,920.00 per year. The highest earning executive at Cogent Biosciences is Mr. Andrew R. Robbins M.B.A., President, CEO & Director, who commands a salary of $1,060,000.00 per year. Learn More on Jessica Sachs' salary.
How do I contact Jessica Sachs?: The corporate mailing address for Sachs and other Cogent Biosciences executives is 2650 NORTH MILITARY TRAIL SUITE 300, BOCA RATON FL, 33431. Cogent Biosciences can also be reached via phone at (617) 945-5576 and via email at [email protected]. Learn More on Jessica Sachs' contact information.
Has Jessica Sachs been buying or selling shares of Cogent Biosciences?: Jessica Sachs has not been actively trading shares of Cogent Biosciences over the course of the past ninety days. Most recently, Jessica Sachs sold 82,642 shares of the business's stock in a transaction on Friday, December 26th. The shares were sold at an average price of $38.70, for a transaction totalling $3,198,245.40. Following the completion of the sale, the insider now directly owns 133,938 shares of the company's stock, valued at $5,183,400.60. Learn More on Jessica Sachs' trading history.
Who are Cogent Biosciences' active insiders?: Cogent Biosciences' insider roster includes John Green (CFO), Evan Kearns (Insider), and Jessica Sachs (Insider). Learn More on Cogent Biosciences' active insiders.
Are insiders buying or selling shares of Cogent Biosciences?: In the last twelve months, Cogent Biosciences insiders bought shares 1 times. They purchased a total of 2,777,777 shares worth more than $24,999,993.00. In the last twelve months, insiders at the technology company sold shares 3 times. They sold a total of 237,642 shares worth more than $9,200,345.40. The most recent insider tranaction occured on December, 26th when insider Evan Kearns sold 65,000 shares worth more than $2,515,500.00. Insiders at Cogent Biosciences own 7.3% of the company. Learn More about insider trades at Cogent Biosciences.
Information on this page was last updated on 12/26/2025.

Jessica Sachs Insider Trading History at Cogent Biosciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
12/26/2025	Sell	82,642	$38.70	$3,198,245.40	133,938

Jessica Sachs Buying and Selling Activity at Cogent Biosciences

Cogent Biosciences Company Overview

Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes bezuclastinib (CGT9486), a selective tyrosine kinase inhibitor designed to target mutations within the KIT receptor tyrosine kinase, including KIT D816V KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. The company has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. The company was formerly known as Unum Therapeutics Inc. and changed its name to Cogent Biosciences, Inc. in October 2020. Cogent Biosciences, Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

Today's Range

Now: $38.26

$35.09

$38.35

50 Day Range

MA: $36.08

$14.42

$42.11

2 Week Range

Now: $38.26

$3.72

$43.73

Volume

882,102 shs

Average Volume

2,274,121 shs

Market Capitalization

$5.45 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.5

Jessica Sachs Biography and Net Worth

What is Jessica Sachs' net worth?

How old is Jessica Sachs?

What is Jessica Sachs' salary?

How do I contact Jessica Sachs?

Has Jessica Sachs been buying or selling shares of Cogent Biosciences?

Who are Cogent Biosciences' active insiders?

Are insiders buying or selling shares of Cogent Biosciences?